RT Journal Article
T1 Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain
A1 Hidalgo, M
A1 Álvarez, R
A1 Gallego, J
A1 Guillén-Ponce, C
A1 Laquente, B
A1 Macarulla, T
A1 Muñoz, A
A1 Salgado, M
A1 Vera, R
A1 Adeva, J
A1 Alés, I
A1 Arévalo, S
A1 Blázquez, J
A1 Calsina, A
A1 Carmona, A
A1 de Madaria, E
A1 Díaz, R
A1 Díez, L
A1 Fernández, T
A1 de Paredes, B G
A1 Gallardo, M E
A1 González, I
A1 Hernando, O
A1 Jiménez, P
A1 López, A
A1 López, C
A1 López-Ríos, F
A1 Martín, E
A1 Martínez, J
A1 Martínez, A
A1 Montans, J
A1 Pazo, R
A1 Plaza, J C
A1 Peiró, I
A1 Reina, J J
A1 Sanjuanbenito, A
A1 Yaya, R
A1 Carrato, Alfredo
K1 Pancreatic cancer
K1 Diagnosis
K1 Treatment
K1 Consensus guidelines
K1 Carcinoma ductal pancreático
K1 Humanos
K1 Neoplasias pancreáticas
K1 Sistemas de lectura
K1 Guía
AB The management of patients with pancreatic cancer has advanced over the last few years. We convey a multidisciplinary group of experts in an attempt to stablish practical guidelines for the diagnoses, staging and management of these patients. This paper summarizes the main conclusions of the working group. Patients with suspected pancreatic ductal adenocarcinoma should be rapidly evaluated and referred to high-volume centers. Multidisciplinary supervision is critical for proper diagnoses, staging and to frame a treatment plan. Surgical resection together with chemotherapy offers the highest chance for cure in early stage disease. Patients with advanced disease should be classified in treatment groups to guide systemic treatment. New chemotherapeutic regimens have resulted in improved survival. Symptomatic management is critical in this disease. Enrollment in a clinical trial is, in general, recommended.
PB Springer Verlag
SN 1699-3055 (online)
YR 2017
FD 2017-06-19
LK http://hdl.handle.net/10668/2724
UL http://hdl.handle.net/10668/2724
LA en
NO Hidalgo M, Álvarez R, Gallego J, Guillén-Ponce C, Laquente B, Macarulla T, et al. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain. Clin Trans Oncol. 2017; 19:667.
NO Funding was provided by Fundación ECO
DS RISalud
RD Apr 8, 2025